Biotech Updates

EFSA Reaffirms Risk Assessment of GM Maize MON 863

July 6, 2007

In March 2007, a CRIIGEN study on the safety of genetically modified (GM) maize MON863 was released, alleging that the GM maize poses health risks at the experimental dose rates.  The European Commission (EC) requested the European Food Safety Authority (EFSA) to examine the statistical analysis of the 90-day rat study. After undertaking a series of actions and reviewing all available evidence, the EFSA GMO Panel concluded that the paper does not present a sound scientific justification in order to question the safety of MON 863 maize. The GMO Panel sees no reason to revise its previous Opinions that the MON 863 maize would not have an adverse effect in the context of its proposed use.

Read the press release at http://www.efsa.europa.eu/etc/medialib/efsa/press_room/press_release/pr_efsa_maize-
mon863.Par.0001.File.dat/pr_efsa_mon863.pdf
.